DUCHENE MUSCULAR DYSTROPHY
Clinical trials for DUCHENE MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new DUCHENE MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for DUCHENE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for duchenne: targeted drug trial aims to slow muscle decline
Disease control Not yet recruitingThis study tests an experimental drug called AOC 1044 (delpacibart zotadirsen) in 70 boys aged 7 to 16 with Duchenne muscular dystrophy who have a specific genetic change (exon 44 skipping). The drug is given through a vein and aims to improve muscle function, such as how fast th…
Matched conditions: DUCHENE MUSCULAR DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Exercise study aims to slow muscle decline in kids with DMD
Symptom relief Not yet recruitingThis study will test whether different types of strengthening exercises can improve muscle strength and walking ability in 45 children aged 6 to 10 with Duchenne muscular dystrophy. Researchers will also measure a chemical marker in the blood called creatine-kinase to see how the…
Matched conditions: DUCHENE MUSCULAR DYSTROPHY
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 17, 2026 12:58 UTC
-
New ultrasound technique could revolutionize how we measure muscle disease
Knowledge-focused Not yet recruitingThis study tests a new, non-invasive ultrasound method to monitor muscle changes in boys and men with Duchenne or Becker muscular dystrophy. Researchers will compare their muscles to those of healthy volunteers and track changes over a year. The goal is to find better ways to mea…
Matched conditions: DUCHENE MUSCULAR DYSTROPHY
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 13:00 UTC